Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louise Nott

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Asia-Pacific Journal of Clinical Oncology|July 20, 2019
Efficacy of late line pertuzumab with trastuzumab and chemotherapy in HER2-positive metastatic breast cancer: An Australian case seriesAlice R T Bergin, Stephen J Luen, Peter Savas, et al.
Internal Medicine Journal|May 18, 2021
Uptake of bone-modifying agents in patients with HER2+ metastatic breast cancer with bone metastases - prospective data from a multi-site Australian registryVanessa Wong, Richard de Boer, Catherine Dunn, et al.
Clinical Colorectal Cancer|January 25, 2016
Primary Tumor Resection and Overall Survival in Patients With Metastatic Colorectal Cancer Treated With Palliative IntentShu Fen Wong, Hui Li Wong, Kathryn M Field, et al.
Clinical Colorectal Cancer|May 24, 2025
Exploring Real-World Outcomes of First Line EGFR Inhibitor Use, Cetuximab Versus Panitumumab, in Patients with Left-Sided, RAS Wild-Type, Metastatic Colorectal CancerJane McKenzie, Vanessa Wong, Shehara Mendis, et al.
Asia-Pacific Journal of Clinical Oncology|April 15, 2015
Novel quality indicators for metastatic colorectal cancer management identify significant variations in these measures across treatment centers in AustraliaNatalie Heather Turner, Hui-Li Wong, Kathryn Field, et al.
Acta Oncologica (Stockholm, Sweden)|July 24, 2018
The survival outcome of patients with metastatic colorectal cancer based on the site of metastases and the impact of molecular markers and site of primary cancer on metastatic patternThiru Prasanna, Christos S Karapetis, David Roder, et al.
Virchows Archiv : an International Journal of Pathology|August 12, 2019
Potentially actionable FGFR2 high-level amplification in thymic sebaceous carcinomaStefan Porubsky, Peter Jessup, Damien Kee, et al.
World Journal of Gastroenterology|May 9, 2015
Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumabAflah Roohullah, Hui-Li Wong, Katrin M Sjoquist, et al.
Pharmacoeconomics|August 18, 2020
Simulating Progression-Free and Overall Survival for First-Line Doublet Chemotherapy With or Without Bevacizumab in Metastatic Colorectal Cancer Patients Based on Real-World Registry DataKoen Degeling, Hui-Li Wong, Hendrik Koffijberg, et al.
Asia-Pacific Journal of Clinical Oncology|February 15, 2019
Right versus left sided metastatic colorectal cancer: Teasing out clinicopathologic drivers of disparity in survivalShehara Mendis, Sophie Beck, Belinda Lee, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Asia-Pacific Journal of Clinical Oncology|July 20, 2019
Efficacy of late line pertuzumab with trastuzumab and chemotherapy in HER2-positive metastatic breast cancer: An Australian case seriesAlice R T Bergin, Stephen J Luen, Peter Savas, et al.
Internal Medicine Journal|May 18, 2021
Uptake of bone-modifying agents in patients with HER2+ metastatic breast cancer with bone metastases - prospective data from a multi-site Australian registryVanessa Wong, Richard de Boer, Catherine Dunn, et al.
Clinical Colorectal Cancer|January 25, 2016
Primary Tumor Resection and Overall Survival in Patients With Metastatic Colorectal Cancer Treated With Palliative IntentShu Fen Wong, Hui Li Wong, Kathryn M Field, et al.
Clinical Colorectal Cancer|May 24, 2025
Exploring Real-World Outcomes of First Line EGFR Inhibitor Use, Cetuximab Versus Panitumumab, in Patients with Left-Sided, RAS Wild-Type, Metastatic Colorectal CancerJane McKenzie, Vanessa Wong, Shehara Mendis, et al.
Asia-Pacific Journal of Clinical Oncology|April 15, 2015
Novel quality indicators for metastatic colorectal cancer management identify significant variations in these measures across treatment centers in AustraliaNatalie Heather Turner, Hui-Li Wong, Kathryn Field, et al.
Acta Oncologica (Stockholm, Sweden)|July 24, 2018
The survival outcome of patients with metastatic colorectal cancer based on the site of metastases and the impact of molecular markers and site of primary cancer on metastatic patternThiru Prasanna, Christos S Karapetis, David Roder, et al.
Virchows Archiv : an International Journal of Pathology|August 12, 2019
Potentially actionable FGFR2 high-level amplification in thymic sebaceous carcinomaStefan Porubsky, Peter Jessup, Damien Kee, et al.
World Journal of Gastroenterology|May 9, 2015
Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumabAflah Roohullah, Hui-Li Wong, Katrin M Sjoquist, et al.
Pharmacoeconomics|August 18, 2020
Simulating Progression-Free and Overall Survival for First-Line Doublet Chemotherapy With or Without Bevacizumab in Metastatic Colorectal Cancer Patients Based on Real-World Registry DataKoen Degeling, Hui-Li Wong, Hendrik Koffijberg, et al.
Asia-Pacific Journal of Clinical Oncology|February 15, 2019
Right versus left sided metastatic colorectal cancer: Teasing out clinicopathologic drivers of disparity in survivalShehara Mendis, Sophie Beck, Belinda Lee, et al.
Pageof 6